A R T I C L E S
Bartels et al.
diffusion and positional disorder, as found in the ld phase,
together with relatively ordered acyl chains, as occurs in the
solid-ordered (so) phase.5,7 The ld phase in these systems
typically contains highly unsaturated lipids with a low phase-
transition temperature, whereas the lo phase predominately
consists of a saturated or sphingolipid component with a high
phase-transition temperature and cholesterol. Analyzing the
thermodynamics and structural properties of such lipid mixtures
remains a challenging task.8 Experiments using fluorescence
techniques have led to substantial progress in understanding the
phase behavior and boundaries in ternary mixtures by their
ability to establish binary and ternary phase diagrams for several
lipid systems of current interest.9 Yet these phase diagrams are
often quite fragmentary at physiologically relevant temperatures
and in some cases can lead to questionable conclusions because
of the need to incorporate a fluorescent probe. This last
disadvantage has recently attracted significant attention, as
changes in phase behavior have been discovered upon addition
of even trace amounts of a fluorescent probe.10
abundance of this lipid in the nervous systems of mammals,
where it becomes increasingly enriched as a result of progression
in age,14 but it poses a synthetic challenge. The normal
semisynthetic pathway, namely, removal of the amide-linked
fatty acyl chain followed by reacylation with a deuterated
derivative, is hampered by partial epimerization at the C3 carbon
of the sphingosine backbone. Despite these difficulties, a
chemical synthesis of optically pure and selectively 2H-labeled
sphingomyelin is needed for an investigation of the putative
role of sphingomyelin in the formation of rafts.
In our studies, we used binary mixtures of cholesterol with
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) or
N-palmitoylsphingomyelin (PSM), in which the palmitoyl chain
of POPC or PSM was perdeuterated, to study the different
effects of cholesterol on the saturated chains of the lipid.
Additionally, we investigated ternary mixtures containing both
lipids and varying cholesterol content at several temperatures
in order to obtain structural information on the lipids for
representative sections of the phase prism of the ternary mixture.
We observed each 2H-labeled lipid component separately, and
using a structural model, we were able to distinguish the order
parameter profile for each component in its respective phase.
For certain ranges of temperature and cholesterol content, lateral
phase separation due to the preferential interaction of cholesterol
with sphingomyelin was demonstrated. However, our data
suggest that little or no phase separation is detectable at
cholesterol mole fractions (XC) greater than 0.33, indicating that
PSM is in a homogeneous phase with POPC and cholesterol.
These concentrations are lower than those implied by published
phase diagrams9,15 and have important implications for lateral
organization and raft formation in biological membranes in vivo.
2
Solid-state H NMR spectroscopy, on the other hand, is a
versatile technique that lends itself to a noninvasive investigation
of the order and mobility of acyl chains and polar headgroups
in lipid bilayers.11,12 The residual quadrupolar couplings (RQCs)
of chain deuterons located within the lipid bilayer can be
evaluated in terms of segmental order parameters and order
parameter distributions, which may also yield knowledge about
partitioning of the lipids into different bilayer domains. Further
interpretation using structural models can provide information
on the mean interfacial area of a lipid or the average length of
the acyl chain projection, which is directly related to the
membrane thickness.12,13 Combining these measurements with
the overall ordering of the acyl chains, which is directly
accessible by solid-state 2H NMR experiments, enables one to
acquire information about the phase behavior of lipids in the
mixtures. Nonetheless, a limitation of this technique is the
availability of selectively deuterated lipid samples. Deuteration
of sphingomyelin is of particular interest because of the
Methods
Chemicals. Synthetic POPC, egg yolk sphingomyelin (EYSM),
cholesterol, and 1-perdeuteriopalmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC-d31) were purchased from Avanti Polar Lipids
(Alabaster, AL). Perdeuterated palmitic acid (palmitic acid-d31) and
deuterium oxide were obtained from Cambridge Isotopes (Promo-
chem GmbH, Wesel, Germany). Labeled N-perdeuteriopalmitoyl-
sphingomyelin (PSM-d31) was synthesized by N-acylation of
D-erythro-sphingosylphosphocholine as described previously.16
Briefly, the p-nitrophenyl ester of palmitic acid-d31 and anhydrous
potassium carbonate were added to lysosphingomyelin (prepared
from EYSM as previously described17) in a mixture of anhydrous
dimethylformamide and dichloromethane under nitrogen, and the
mixture was stirred at ambient temperature for 1 day. The products
were purified by silica gel column chromatography (eluting with
65:35:5 chloroform/methanol/water), and the suspended silica gel
was removed by filtration. Purity was checked by thin-layer
chromatography and liquid chromatography/mass spectrometry.
Lipid Sample Preparation. Oriented lipid multibilayers were
prepared and macroscopically aligned as described elsewhere.18,19
Briefly, 30 mg of the lipid or lipid mixture containing at least 12
mg of deuterated material was dissolved in 2.5 mL of tert-butyl
(3) (a) Brown, D. A.; Rose, J. K. Cell 1992, 68, 533–544. (b) Cinek, T.;
Horejsi, V. J. Immunol. 1992, 149, 2262–2270.
(4) (a) Schroeder, R. J.; Ahmed, S. N.; Zhu, Y.; London, E.; Brown, D. A.
J. Biol. Chem. 1998, 273, 1150–1157. (b) Ilangumaran, S.; Hoessli,
D. C. Biochem. J. 1998, 335, 433–440. (c) Green, J. M.; Zhelesnyak,
A.; Chung, J.; Lindberg, F. P.; Sarfati, M.; Frazier, W. A.; Brown,
E. J. J. Cell Biol. 1999, 146, 673–682. (d) Roy, S.; Luetterforst, R.;
Harding, A.; Apolloni, A.; Etheridge, M.; Stang, E.; Rolls, B.;
Hancock, J. F.; Parton, R. G. Nat. Cell Biol. 1999, 1, 98–105. (e)
Anderson, H. A.; Hiltbold, E. M.; Roche, P. A. Nat. Immunol. 2000,
1, 156–162.
(5) Ipsen, J. H.; Karlström, G.; Mouritsen, O. G.; Wennerström, H.;
Zuckermann, M. J. Biochim. Biophys. Acta 1987, 905, 162–172.
(6) London, E. Biochim. Biophys. Acta 2005, 1746, 203–220.
(7) (a) Ipsen, J. H.; Mouritsen, O. G.; Zuckermann, M. J. Biophys. J. 1989,
56, 661–667. (b) Sankaram, M. B.; Thompson, T. E. Biochemistry
1990, 29, 10670–10675. (c) Mouritsen, O. G.; Zuckermann, M. J.
Lipids 2004, 39, 1101–1113. (d) Veatch, S. L.; Soubias, O.; Keller,
S. L.; Gawrisch, K. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 17650–
17655.
(8) de Almeida, R. F.; Fedorov, A.; Prieto, M. Biophys. J. 2003, 85, 2406–
2416.
(14) (a) Barenholz, Y.; Thompson, T. E. Biochim. Biophys. Acta 1980,
604, 129–158. (b) Cutler, R. G.; Mattson, M. P. Mech. Ageing DeV.
2001, 122, 895–908.
(9) Veatch, S. L.; Keller, S. L. Biophys. J. 2003, 85, 3074–3083.
(10) Veatch, S. L.; Leung, S. S.; Hancock, R. E.; Thewalt, J. L. J. Phys.
Chem. B 2007, 111, 502–504.
(15) Veatch, S. L.; Keller, S. L. Phys. ReV. Lett. 2005, 94, 148101-1–
148101-4.
(11) Gawrisch, K.; Eldho, N. V.; Polozov, I. V. Chem. Phys. Lipids 2002,
116, 135–151.
(16) Mehnert, T.; Jacob, K.; Bittman, R.; Beyer, K. Biophys. J. 2006, 90,
939–946.
(12) Brown, M. F.; Lope-Piedrafita, S.; Martinez, G. V.; Petrache, H. I. In
Modern Magnetic Resonance; Webb, G. A., Ed.; Springer: Berlin,
2006; pp 245-256.
(17) Bittman, R.; Verbicky, C. A. J. Lipid Res. 2000, 41, 2089–2093.
(18) Kurze, V.; Steinbauer, B.; Huber, T.; Beyer, K. Biophys. J. 2000, 78,
2441–2451.
(13) Petrache, H. I.; Dodd, S. W.; Brown, M. F. Biophys. J. 2000, 79,
3172–3192.
(19) Steinbauer, B.; Mehnert, T.; Beyer, K. Biophys. J. 2003, 85, 1013–
1024.
9
14522 J. AM. CHEM. SOC. VOL. 130, NO. 44, 2008